Drug Target Review

SEPTEMBER 10, 2024

Drug developer companies across the pharma industry report notable reductions in drug development timelines where 10 to 12 months, from lead monoclonal antibody (mAb) identification to IND application, is the new norm and in which earlier Tox material generation has been a critical component for shortening IND timelines.

Drug Development 64

Drug Development Clinical Supply Production FDA 64

LifeSciVC

AUGUST 21, 2024

For others this may serve as a reminder of some of the pitfalls that can befall biotech companies this time of year and what the key questions are to ask yourself and the team to manage through the madness and finish strong in 2024. Clinical Trials Are your clinical trials on track?

Clinical Trials 70

Clinical Trials Trials Disease Treatment 70

PPD

FEBRUARY 3, 2025

Critical focus areas to fast-track your clinical trials In the race to bring therapies to market faster, sponsors can gain a competitive edge by addressing three critical areas in their clinical development strategy: artificial intelligence (AI), integrated solutions, and site feasibility, selection and support.

Clinical Trials 52

Clinical Trials Trials Clinical Supply Drug Development 52